Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 50978-11-5
2. Amidotrizoic Acid Dihydrate
3. 3,5-diacetamido-2,4,6-triiodobenzoic Acid Dihydrate
4. Chebi:59733
5. Unii-408463f217
6. Dsstox_cid_28886
7. Dsstox_rid_83154
8. Dsstox_gsid_48960
9. 2,4,6-triiodo-3,5-diacetamidobenzoic Acid Dihydrate
10. 408463f217
11. 3,5-bis(acetylamino)-2,4,6-triiodobenzoic Acid Dihydrate
12. 3,5-diacetamido-2,4,6-triiodobenzoic Acid--water (1/2)
13. Cas-50978-11-5
14. Ncgc00021123-02
15. Amidotrizoic Acid [ban:jan]
16. 3,5-diacetamido-2,4,6-triiodobenzoic Acid;dihydrate
17. Chembl3188504
18. Dtxsid1048960
19. Hms3715h18
20. Act05335
21. Amy33530
22. Tox21_113395
23. Mfcd06408002
24. Akos025310142
25. Tox21_113395_1
26. Ccg-221238
27. Ncgc00021123-03
28. As-13492
29. Ft-0652238
30. Amidotrizoic Acid, Dehydrate [who-ip]
31. D96087
32. 3,5-diacetamido-2,4,6-triiodobenzoicaciddihydrate
33. Amidotrizoic Acid Dihydrate [ep Monograph]
34. Sr-01000003031
35. Sr-01000003031-5
36. Q27126875
37. Acidum Amidotrizoicum, Dehydrate [who-ip Latin]
38. Benzoic Acid, 3,5-bis(acetylamino)-2,4,6-triiodo-, Hydrate (1:2)
1. Amidotrizoic Acid
2. Diatrizoic Acid
3. Diatrizoate
| Molecular Weight | 649.94 g/mol |
|---|---|
| Molecular Formula | C11H13I3N2O6 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 649.7908 g/mol |
| Monoisotopic Mass | 649.7908 g/mol |
| Topological Polar Surface Area | 97.5 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 391 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Diatrizoic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diatrizoic Acid, including repackagers and relabelers. The FDA regulates Diatrizoic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diatrizoic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diatrizoic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diatrizoic Acid supplier is an individual or a company that provides Diatrizoic Acid active pharmaceutical ingredient (API) or Diatrizoic Acid finished formulations upon request. The Diatrizoic Acid suppliers may include Diatrizoic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Diatrizoic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diatrizoic Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of Diatrizoic Acid active pharmaceutical ingredient (API) in detail. Different forms of Diatrizoic Acid DMFs exist exist since differing nations have different regulations, such as Diatrizoic Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diatrizoic Acid DMF submitted to regulatory agencies in the US is known as a USDMF. Diatrizoic Acid USDMF includes data on Diatrizoic Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diatrizoic Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diatrizoic Acid suppliers with USDMF on PharmaCompass.
A Diatrizoic Acid CEP of the European Pharmacopoeia monograph is often referred to as a Diatrizoic Acid Certificate of Suitability (COS). The purpose of a Diatrizoic Acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Diatrizoic Acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Diatrizoic Acid to their clients by showing that a Diatrizoic Acid CEP has been issued for it. The manufacturer submits a Diatrizoic Acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a Diatrizoic Acid CEP holder for the record. Additionally, the data presented in the Diatrizoic Acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Diatrizoic Acid DMF.
A Diatrizoic Acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Diatrizoic Acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Diatrizoic Acid suppliers with CEP (COS) on PharmaCompass.
A Diatrizoic Acid written confirmation (Diatrizoic Acid WC) is an official document issued by a regulatory agency to a Diatrizoic Acid manufacturer, verifying that the manufacturing facility of a Diatrizoic Acid active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diatrizoic Acid APIs or Diatrizoic Acid finished pharmaceutical products to another nation, regulatory agencies frequently require a Diatrizoic Acid WC (written confirmation) as part of the regulatory process.
click here to find a list of Diatrizoic Acid suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diatrizoic Acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diatrizoic Acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diatrizoic Acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diatrizoic Acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diatrizoic Acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diatrizoic Acid suppliers with NDC on PharmaCompass.
Diatrizoic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diatrizoic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diatrizoic Acid GMP manufacturer or Diatrizoic Acid GMP API supplier for your needs.
A Diatrizoic Acid CoA (Certificate of Analysis) is a formal document that attests to Diatrizoic Acid's compliance with Diatrizoic Acid specifications and serves as a tool for batch-level quality control.
Diatrizoic Acid CoA mostly includes findings from lab analyses of a specific batch. For each Diatrizoic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diatrizoic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Diatrizoic Acid EP), Diatrizoic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diatrizoic Acid USP).
LOOKING FOR A SUPPLIER?
